Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Cancer Biol Med. 2021 Jul 14;19(8):1274-81. doi: 10.20892/j.issn.2095-3941.2021.0108.
To study the efficacy of the enhanced recovery after surgery (ERAS) program on postoperative recovery and complications in patients with gastric cancer.
Eighty patients in the perioperative period with radical gastrectomy were enrolled and randomly divided into 2 groups, the ERAS group and the non-ERAS group. The differences between the 2 groups in terms of postoperative recoveries and complications rate were determined. According to the body mass index (BMI) level, the ERAS group was divided into 2 subgroups, namely group A (BMI < 28 kg/m, = 16) and group B (BMI ≥ 28 kg/m, = 24). The non-ERAS group was also divided into group C (BMI < 28 kg/m, = 18) and group D (BMI ≥ 28 kg/m, = 22). The recovery and complications of each group were then determined.
The postoperative length of stay and visual analogue scale pain score were less in the ERAS group than the non-ERAS group ( < 0.05). Time to first postoperative exhaustion, first postoperative defecation, returning leukocyte count to normal, and stopping intravenous nutrition were significantly shorter in the ERAS group ( = 40), compared to the non-ERAS group ( = 40, all < 0.05). The incidence of postoperative lower extremity intramuscular venous thrombosis was significantly higher in group D than in group B (χ = 4.800, = 0.028). In addition, the incidence of lower extremity intermuscular venous thrombosis and lung infection in group D was higher than those in other groups.
The perioperative ERAS program was associated with faster recovery in patients undergoing radical gastrectomy. For patients with higher BMI (BMI ≥ 28 kg/m), the use of the perioperative ERAS program was more advantageous.
研究加速康复外科(ERAS)方案对胃癌患者术后恢复和并发症的影响。
选择 80 例接受根治性胃切除术的围手术期患者,随机分为 ERAS 组和非 ERAS 组。比较两组患者术后恢复情况及并发症发生率。根据体质量指数(BMI)水平,将 ERAS 组分为两组,A 组(BMI<28 kg/m2,n=16)和 B 组(BMI≥28 kg/m2,n=24)。非 ERAS 组也分为 C 组(BMI<28 kg/m2,n=18)和 D 组(BMI≥28 kg/m2,n=22)。然后确定每组的恢复情况和并发症。
与非 ERAS 组相比,ERAS 组患者术后住院时间和视觉模拟评分疼痛量表(VAS)评分较低(<0.05)。ERAS 组首次术后疲劳、首次术后排便、白细胞计数恢复正常和停止静脉营养的时间明显短于非 ERAS 组(=40,均<0.05)。D 组术后下肢肌间静脉血栓形成发生率明显高于 B 组(χ=4.800,=0.028)。此外,D 组下肢肌间静脉血栓形成和肺部感染的发生率高于其他组。
围手术期 ERAS 方案可加快胃癌根治术患者的恢复速度。对于 BMI 较高(BMI≥28 kg/m2)的患者,围手术期 ERAS 方案的应用更具优势。